CD25-SPECIFIC ANTIBODIES AND USES THEREOF
Technology
E-129-2022
Patent ID
E-129-2022-0-US-02
Country
US
Application Type
National Stage
Patent Status
Pending
Patent Number
Publication Number
US-2025-0387484-A1
Application Number
18/878,317
IC
NCI
Date Filed
Date Issued
Patent PDF